Trial Profile
Safety of a Quadrivalent Influenza Vaccine (VaxigripTetra™) in Subjects Aged 6 Months and Older in Vietnam
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jul 2019
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Sanofi Pasteur
- 09 Apr 2019 Status changed from active, no longer recruiting to completed.
- 22 Feb 2019 Status changed from recruiting to active, no longer recruiting.
- 13 Feb 2019 Status changed from not yet recruiting to recruiting.